Hepatic and splenic venous access tract closure using the VASCADE vascular closure system following percutaneous intervention in patients with CHD
VASCADE can be used following transhepatic and trans-splenic venous access in the cardiac catheterisation laboratory to safely close the access tract and potentially reduce the risk of post-procedural bleeding complications. Further evaluation in a larger cohort of patients is needed to ensure VASCADE is safe for use and provides adequate haemostasis following hepatic or splenic venous access, particularly in children.
Authors
- Lindsay Eilers (ORCID: https://orcid.org/0000-0002-4425-1405)
- Manish Bansal (ORCID: https://orcid.org/0000-0002-2125-8073)
- Srinath T. Gowda (ORCID: https://orcid.org/0000-0002-8580-722X)
- Asra Khan (ORCID: https://orcid.org/0000-0001-9653-0388)
- Gary Stapleton (ORCID: https://orcid.org/0000-0001-8466-1401)
- Athar M. Qureshi (ORCID: https://orcid.org/0000-0001-5992-568X)
- Melissa K. Webb
Institutions
- Texas Children's Hospital (US)
Publication Details
- Journal
- Cardiology in the Young
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1017/s1047951124025538
- Citations
- 1
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 0.74